CVR: 39724758
DKK -2,128,863
Gross profit
Net result: DKK -5,168,999
Bente Kristiansen, Rossi Finans ApS
2 more
CVR · view ownership and management
Owner registered: Bente Kristiansen
CVR · 01/05/2026
View the full event history
GlyProVac ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Anders Boysen and Ann Zahle Andersen. The company's owners include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -2,128,863 and a net result of DKK -5,168,999 compared with DKK -3,014,952 the year before. Equity in the 2025 report amounted to DKK -831,720.
Selskabets formål er udvikle, kommercialisere, fremstille og sælge bakterielle vacciner.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | -2.1 mio. | -5.2 mio. | 4.6 mio. | -832 t. | 6 | |
| 202401/07/2023 – 30/06/2024 | -577 t. | -3 mio. | 4.4 mio. | -654 t. | 5 | |
| 202301/07/2022 – 30/06/2023 | -815 t. | -2.9 mio. | 5.5 mio. | 852 t. | 4 | |
| 202201/07/2021 – 30/06/2022 | 1.3 mio. | -633 t. | 12.2 mio. | 5 mio. | 4 | |
| 202101/07/2020 – 30/06/2021 | 993 t. | -487 t. | 9.5 mio. | 2.4 mio. | 3 | |
| 202001/07/2019 – 30/06/2020 | 1.1 mio. | -699 t. | 3.7 mio. | 672 t. | 4 | |
| 201903/07/2018 – 30/06/2019 | 145 t. | -918 t. | 2.6 mio. | 1.4 mio. | 2 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationGlyProVac ApS was founded on 3 July 2018.
GlyProVac ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
GlyProVac ApS had 3 employees in 2018 according to the Danish CVR register.
The owners of GlyProVac ApS include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej.
In 2025, GlyProVac ApS reported a gross profit of DKK -2,128,863.
The management of GlyProVac ApS consists of Anders Boysen and Ann Zahle Andersen.
Claim this page to add your logo and social links. Free to get started.
As of June 11, 2026, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.
As of June 10, 2026, Ann Zahle Andersen has left the board of directors of GlyProVac ApS.
As of May 19, 2026, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.
As of May 1, 2026, Bente Kristiansen is registered as an owner of GlyProVac ApS with an ownership share of 10%.
GlyProVac ApS has published its annual report for 2025. Gross profit came to DKK -2,128,863, and the net result was DKK -5,168,999.
GlyProVac ApS has published its annual report for 2024. Gross profit came to DKK -577,426, and the net result was DKK -3,014,952.
GlyProVac ApS has published its annual report for 2023. Gross profit came to DKK -814,748, and the net result was DKK -2,871,688.
As of October 5, 2023, Kirsten Winther has joined the board of directors of GlyProVac ApS.
As of October 5, 2023, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.
As of October 4, 2023, Kirsten Winther has left the board of directors of GlyProVac ApS.
As of October 4, 2023, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.
As of September 28, 2023, Rossi Finans ApS is registered as an owner of GlyProVac ApS with an ownership share of 10%.
GlyProVac ApS has published its annual report for 2022. Gross profit came to DKK 1,321,135, and the net result was DKK -633,455.
As of March 1, 2022, Allan Rosetzsky has joined the board of directors of GlyProVac ApS.
As of March 1, 2022, Anders Boysen has left the board of directors of GlyProVac ApS.
As of March 1, 2022, I/S Rødeledsvej is registered as an owner of GlyProVac ApS with an ownership share of 5%.
As of March 1, 2022, GlycoPharma Holding ApS is registered as an owner of GlyProVac ApS with an ownership share of 33%.
As of January 1, 2022, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.
GlyProVac ApS has published its annual report for 2021. Gross profit came to DKK 993,453, and the net result was DKK -487,049.
As of August 29, 2021, Willem Adriaan de Jongh has joined the board of directors of GlyProVac ApS.
GlyProVac ApS has published its annual report for 2020. Gross profit came to DKK 1,050,949, and the net result was DKK -698,589.
GlyProVac ApS has published its annual report for 2019. Gross profit came to DKK 145,314, and the net result was DKK -917,733.
As of January 29, 2019, Kirsten Winther has joined the board of directors of GlyProVac ApS.
As of January 25, 2019, Peter Smedegaard has left the board of directors of GlyProVac ApS.
As of July 3, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GlyProVac ApS.
As of July 3, 2018, Peter Smedegaard has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Anders Boysen has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Anders Boysen is registered as adm. dir. of GlyProVac ApS.
As of July 3, 2018, Ann Zahle Andersen is registered as director of GlyProVac ApS.
GlyProVac ApS was founded on July 3, 2018.
Companies in the same industry and area
